Skip to main content

The rockefeller university

News & HighlightsNews
Pharma exec, editor to be university's first visiting scholars
by TALLEY HENNING BROWN For a few weeks this fall, talk on campus will step beyond basic science. Former pharmaceutical executive Peter Goodfellow and Nature editor in chief Philip Campbell will join The Rockefeller University this month as its first visiting scholars. The Visiting Scholars Progr...
Why visiting scholars?
One of the strategic aims identified in the plan for the university is to foster interactions among scientists at all levels. Over the past few years we have introduced a number of vehicles to encourage greater intellectual exchange. These include the Monday Lecture Series, now entering its third...
Princeton physicist joins Rockefeller as part-time visiting professor
by TALLEY HENNING BROWN There’s more than one way to visit. While Peter Goodfellow and Philip Campbell will each spend a few weeks here as visiting scholars, William Bialek has committed to a longer-term stay as a part-time visiting professor. A theoretical physicist and professor at Princeton U...
Milestones
Awarded: Sean Brady, a 2007 Beckman Young Investigator Award, for his work in the discovery and study of naturally occurring small molecules and their therapeutic potential. The award, which comes with a grant of approximately $300,000, was established in 1991 by the Arnold and Mabel Beckman Foun...
Sean Brady named 2007 Beckman Young investigator
Chemical biologist Sean Brady, head of Rockefeller University’s Laboratory of Genetically Encoded Small Molecules, is one of this year’s Beckman Young Investigators. One of 16 awardees this year, Brady was chosen by the Arnold and Mabel Beckman Foundation for his work in the discovery and study ...
Immune cells can simultaneously stimulate and inhibit killer cell activity
Dendritic cells, which are responsible for teaching other immune cells to attack infected or mutated cells, face a dangerous predicament. To demonstrate that an enemy has invaded, they must change to look a little bit like the invader. And once they look like an enemy, they risk being treated lik...
Balancing act protects vulnerable cells from cancer
When a cell loses some of its weapons to fight cancer, it can still look healthy and act normally — if not forever, at least for a while. In research published in the October 15 issue of Cancer Cell, Rockefeller University scientists show how cells lacking a key receptor in a tumor-suppressing pa...
Accessory protein determines whether pheromones are detected
heromones are like the molecules you taste as you chomp on a greasy french fry: big and fatty. In research to be published in the October 17 advance online issue of Nature, Rockefeller University researchers reveal an unanticipated role for a new CD36-like protein to help cells detect these invis...
Newly solved structure reveal how cells resist oxygen damage
The sun’s rays give life, but also take it away. Singlet oxygen, a byproduct of the photosynthetic process by which certain cells convert sunlight into energy, is a highly toxic and reactive substance that tears cells apart. Now, in a study that took more than five years to complete, Rockefeller ...
Jeffrey Ravetch elected to Institute of Medicine
Jeffrey V. Ravetch, head of Rockefeller University’s Leonard Wagner Laboratory of Molecular Genetics and Immunology, has been elected to the Institute of Medicine. Ravetch is one of 65 new members and four foreign associates whose election was announced today at the institute’s annual meeting at...
View
View